You can use your existing Medical Independent, MediLearning or PharmacistCPD account to log in. is Ireland's only investigative medical news website for doctors, healthcare professionals and anyone with an interest in health issues.

Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.

Address: Top Floor, 111 Rathmines Road Lr, Dublin 6

Tel: 353 (01) 441 0024

GreenCross Publishing is owned by Graham Cooke.

The benefits of registering: only registered users:
  • receive the ecCopy two days prior to the printed edition.
  • have automatic access to our free CPD sites.
  • can partake in our online MCQs.
  • can enter our online sports quiz.

Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.

Download the new Mindo app for both IOS & Android.

  • Get notified when a story goes live
  • Access Premium Content
  • Read Offline
[the_ad_placement id="main-ldb-public"]
[the_ad_placement id="main-ldb-mobile-public"]

You are reading 1 of 2 free-access articles allowed for 30 days

ESC and ICS ‘to become even closer’ — ECS President-Elect

By Dermot - 01st Nov 2019 | 22 views

Prof Stephan Achenbach, President-Elect of the European Society of Cardiology (ESC), spoke exclusively with the Medical Independent (MI) at the recent Irish Cardiac Society (ICS) Annual Scientific Meeting and AGM about the perception of Irish cardiologists abroad and the ever-growing links between the two societies.

“The ESC greatly values the ICS, for two main reasons,” explained Prof Achenbach. “First of all, we value the ICS because of the unbelievably high level of professional expertise, but also, as my colleagues and myself have observed, the way in which this Society nurtures the young [cardiologists],” he told MI.

“Even during training, very early on, the young people on their way to becoming cardiologists are perceived as being ‘part of the family’ in the ICS and receive fantastic support, and that’s something that is very unusual. In many other countries, there is no such support – sometimes these younger individuals are perhaps seen as competition in some way. But the sentiment that I have about the model here is that it is a really nurturing relationship and environment for future cardiologists. That is something that seems exceptional to me and I am very impressed by it.”

Prof Achenbach was also asked whether his role as President of the ESC will involve maintaining and strengthening collaborations and links with the ICS. “That is one of the areas I will focus on during my presidency,” he said.

“My plan is to make the ties between the ESC and the ICS even closer than they are already. We in the ESC must not forget that it was actually the national cardiac societies which founded us in 1950 – there were 14 national societies initially that founded the ESC and the national cardiac societies are the basis for everything we do.

“Some national cardiac societies are different from others because they speak English as their native language – that is good and automatically makes the distance between these national cardiac societies a little bit smaller, because otherwise, we face an additional challenge because some of the practitioners may not be fluent in English, and their patients may not be fluent either,” he explained.

“This is why the native English-speaking countries have an advantage to begin with but even with all that said, it is certainly my plan to make the ESC and the ICS even closer than they have been in the past.”

The ESC and ICS together face huge challenges in driving cardiac care due to the ever-increasing population-level issues of the obesity epidemic and ageing populations and Prof Achenbach acknowledged that both societies must rise to these challenges. “We all have our hands full,” he told MI. “The population is changing – we have had successes in treating cardiovascular disease, as well as other successes in areas such as oncology. This makes our patient population older, but these people also have more comorbidities.

“This is challenging, for two reasons,” he continued. “First of all, [utilising] the sheer effort, expenses and resources that are necessary to care for everybody will be challenging, but also, when you think about it, most of the studies that we base our treatments on are in patients who are young – or at least are not very old and don’t have many comorbidities – and often, patients who are older and have many comorbidities are excluded. So we need to adapt and realise that for many of the patients we treat, the scientific data does not apply. That’s something that needs to find its way into the guidelines in the future and will become more and more important.”

Leave a Reply

[the_ad_placement id="main-ldb-public-2"]
[the_ad_placement id="main-ldb-mobile-public-2"]
Latest Issue
The Medical Independent – 24 June 2021

You need to be logged in to access this content. Please login or sign up using the links below.

[the_ad_placement id="main-mpu-public"]
Most Read
[the_ad_placement id="main-ldb-public-2"]
[the_ad_placement id="main-ldb-mobile-public-2"]